Prospect Venture Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2

- Investments
-
134
- Portfolio
-
2
- Exits
-
69

Prospect Venture Partners General Information
Description
Prospect Venture Partners is a life science venture capital firm that seeks to invest in seed to growth stage biomedical companies. The firm was founded in 1997 and is based in Palo Alto, California.
Contact Information
Website
www.prospectventures.com
Year Founded
1997
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 525 University Avenue
- Suite 1350
- Palo Alto, CA 94301
- United States
+1 (650) 000-0000
Prospect Venture Partners Investments & Acquisitions (134)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Mobile Posse | 01-Apr-2018 | Later Stage VC | Business/Productivity Software | Generating Revenue | ||
00000000000 | 27-Sep-2016 | 00000 00000 | 0000 | Surgical Devices | Generating Revenue | 0000000 000000 00.0 |
000000000 0000000 | 25-Nov-2015 | 00000 00000 | 000.00 | Diagnostic Equipment | Bankruptcy: Admin/Reorg | 0000000 000000 00.0 |
000 00000000000000 | 23-Feb-2015 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | 00000 0000000 00 |
0000000 0000000000 | 01-Aug-2014 | 00000 00000 | Drug Discovery | Startup | 00000 0000000 00 | |
0000 000000000000 | 17-Apr-2014 | 00000 00000 | 0000 | Pharmaceuticals | Out of Business | 000000 000000 00. |
000000000 0000000 | 20-Mar-2014 | 00000 00000 | 000.00 | Diagnostic Equipment | Bankruptcy: Admin/Reorg | 0000000 000000 00.0 |
0000000 0000000 | 19-Mar-2014 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue | 0000000 000000 00.0 |
NGM Biopharmaceuticals | 18-Jul-2013 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue/Not Profitable | 00000 0000000 00 |
Topica Pharmaceuticals | 10-Jun-2013 | Later Stage VC | 0000 | Pharmaceuticals | Out of Business | 000000000 000000 00.0 |
Prospect Venture Partners Exits (69)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
NinePoint Medical | 16-Oct-2020 | Bankruptcy: Admin/Reorg | |
00000000000 | 13-Aug-2019 | 000000000000000000 | 00000 |
000 00000000000000 | 04-Apr-2019 | 000 | 00000 |
000000 | 10-Dec-2018 | 000 00 00000000 | |
000000 00000 | 01-May-2018 | 00000000 000000 00 | |
0000 000000000000 | 01-Jan-2017 | 000 00 00000000 | |
000000 0000000 | 27-Jul-2016 | 000000000000000000 | 00000 |
00000 (0000000000 | 06-Jul-2016 | 000000000000000000 | 000.00 |
Topica Pharmaceuticals | 03-May-2016 | Out of Business | |
Vitae Pharmaceuticals | 29-Mar-2016 | Secondary Transaction - Open Market |
Prospect Venture Partners Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Prospect Venture Partners Investments by Industry, Year, and Region
Prospect Venture Partners Team (14)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
David Schnell MD | Co-Founder & Managing Director | 00 | 0 | Palo Alto, CA | |
Russell Hirsch Ph.D | Managing Director | 00 | 0 | 0 | Palo Alto, CA |
Donald Hayden Jr. | Senior Advisor | 0 | 0 | 0 | Palo Alto, CA |